Exciva
0 followers
About Exciva
Exciva GmbH is a privately held biotech company founded in 2016 in Heidelberg, Germany, focused on developing clinical-stage therapeutics for neuropsychiatry indications. The company aims to address neuropsychiatric symptoms of dementia, including agitation in Alzheimer’s disease, through cutting-edge research and rigorous clinical trials. Its lead program EXV-802 has progressed in development for treatment of agitation in dementia associated with Alzheimer’s disease, reflecting a commitment to improving quality of life for patients and support for caregivers.